On Thursday, 8th December 2022, the Blood Products Advisory Committee (BBPAC) of the US FDA the committee will meet in open session to hear an overview of the research programs of the Laboratory of Emerging Pathogens and the Laboratory of Molecular Virology, Division of Emerging and Transfusion Transmitted Diseases, Office of Blood Research and Review, Center for Biologics Research. After the open session, the meeting will be closed to the public for committee deliberations.